Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
gptkb:N05AX12
|
| gptkbp:CASNumber |
129722-12-9
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Servier_Laboratories
|
| gptkbp:hasMolecularFormula |
C17H19FN2O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
D08342
|
| gptkbp:mechanismOfAction |
5-HT2C antagonist
melatonergic agonist |
| gptkbp:PubChem_CID |
gptkb:D08342
6918493 DB06716 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:Agomelatine
|
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:oxycodone
|
| gptkbp:bfsLayer |
7
|